Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10897548 | Cancer Epidemiology | 2014 | 7 Pages |
Abstract
The current population-based report describes a major increase in HCC survival. Simultaneously an increased use of TACE has been detected, probable cofactor of the observed survival increase. Possibly additional efforts could be made to decrease the HCC stage at diagnosis through active surveillance of cirrhotic patients to allow an increase in curative treatments. For sure efforts should be made to comply with a standardised staging system for HCC, particularly for comparative population-based issues.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrea Bordoni, Andreas Cerny, Florian Bihl, Mario Alerci, Paola Mazzola, Simona Peverelli, Gianluigi Marini, Pietro Majno, Luca Mazzucchelli, Alessandra Spitale,